Joseph A DiGiuseppe

Summary

Affiliation: Hartford Hospital
Country: USA

Publications

  1. ncbi request reprint Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy
    Joseph A DiGiuseppe
    Department of Pathology and Laboratory Medicine, Special Hematology Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102 5037, USA
    Clin Lab Med 27:533-49, vi. 2007
  2. doi request reprint Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection
    Joseph A DiGiuseppe
    Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut 06102 5037, USA
    Cytometry B Clin Cytom 76:150-5. 2009
  3. doi request reprint Improved compensation of the fluorochrome AmCyan using cellular controls
    Joseph A DiGiuseppe
    Special Hematology Laboratory, Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, Connecticut 06102 5037, USA
    Cytometry B Clin Cytom 80:191-4. 2011
  4. doi request reprint Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia
    Matthew T Hurford
    Department of Pathology and Laboratory Medicine, Temple University Medical Center, Philadelphia, PA 19140, USA
    Am J Clin Pathol 129:700-5. 2008
  5. ncbi request reprint Flow cytometric immunophenotyping of plasmacytic neoplasms
    Joseph A DiGiuseppe
    Am J Clin Pathol 127:172-4. 2007

Collaborators

  • Michael Borowitz
  • Matthew T Hurford
  • Bradford J Sherburne
  • William N Rezuke
  • Arnold J Altman

Detail Information

Publications5

  1. ncbi request reprint Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy
    Joseph A DiGiuseppe
    Department of Pathology and Laboratory Medicine, Special Hematology Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102 5037, USA
    Clin Lab Med 27:533-49, vi. 2007
    ..Flow cytometric detection of minimal residual disease is among the strongest prognostic factors in patients who have ALL and may provide an opportunity for more precise risk-adapted therapies...
  2. doi request reprint Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection
    Joseph A DiGiuseppe
    Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut 06102 5037, USA
    Cytometry B Clin Cytom 76:150-5. 2009
    ..However, whether CD49f might be a useful reagent in the immunophenotypic detection of MRD in pB-ALL has not been evaluated...
  3. doi request reprint Improved compensation of the fluorochrome AmCyan using cellular controls
    Joseph A DiGiuseppe
    Special Hematology Laboratory, Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, Connecticut 06102 5037, USA
    Cytometry B Clin Cytom 80:191-4. 2011
    ....
  4. doi request reprint Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia
    Matthew T Hurford
    Department of Pathology and Laboratory Medicine, Temple University Medical Center, Philadelphia, PA 19140, USA
    Am J Clin Pathol 129:700-5. 2008
    ..The nuclear pattern of immunofluorescence using antibodies to TdT is an effective method for distinguishing hematogones from leukemic blasts...
  5. ncbi request reprint Flow cytometric immunophenotyping of plasmacytic neoplasms
    Joseph A DiGiuseppe
    Am J Clin Pathol 127:172-4. 2007